TRPV2 and esophageal squamous cell carcinoma: Activation of TRPV2 or its overexpression was found to promote invasiveness of prostate cancer cells and is associated with advanced pathological stage in esophageal squamous cell carcinoma, respectively (Liberati et al., 2014b; Kudou et al., 2019).